Evidence map›Paper›PMID 33977164›Full record

ReviewHealth science reports2021

A concise review on factors influencing the hematopoietic stem cell transplantation main outcomes.

Mohammad Rafiee, Mohammad Abbasi, Hassan Rafieemehr, Amin Mirzaeian, Mohieddin Barzegar, Vahid Amiri, Shaghayegh Shahsavan, Mohammad Hossein Mohammadi

Abstract readReview
In one paragraph

Review in Health science reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mohammad RafieeDepartment of Hematology and Blood Banking School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences Tehran Iran.
Mohammad AbbasiDepartment of Internal Medicine Hamadan University of Medical Sciences Hamadan Iran.
Hassan RafieemehrDepartment of Medical Laboratory Sciences School of Paramedicine, Hamadan University of Medical Sciences Hamadan Iran.
Amin MirzaeianHematopoietic Stem Cells Transplantation Research Center, Laboratory and Blood Banking Department, School of Allied Medical Sciences Shahid Beheshti University of Medical Sciences Tehran Iran.
Mohieddin BarzegarDepartment of Hematology and Blood Banking School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences Tehran Iran.
Vahid AmiriDepartment of Hematology and Blood Banking School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences Tehran Iran.
Shaghayegh ShahsavanStem Cell Transplantation and Cell Therapy Center Taleghani Hospital Tehran Iran.
Mohammad Hossein MohammadiDepartment of Hematology and Blood Banking School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0000-0002-8697-1371

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsAs a curative procedure, hematopoietic stemcell transplantation (HSCT) is an approved treatment for many malignant orbenign hematologic and non-hematologic diseases. There are different outcomes of HSCT, as well as several parameters influencing these outcomes.

methodsWe had searched scientific sources like Web ofScience and PubMed with a combination of keywords such as HSCT, engraftment,survival, outcomes, etc. Totally, 80 articles were included.

resultsHere we have reviewed the effective factors onmain outcomes of HSCT including engraftment, survival, graft versus hostdisease, and Mobilization. Also, the prediction of hematological reconstitutionand some novel suggestions leading to better outcomes are reviewed.

conclusionThe study will be applicable for improvedmanagement of autologous and allogeneic HSCT process to increase the procedureefficiency.

Indexed as

engraftmentgraft vs host diseasehematopoietic stem cell transplantationoutcomesrelapsesurvival

Identifiers

PMID33977164
PMCPMC8103082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.